In the ”Future Clinical Trials”, VEIL.AI helped Bayer to anonymize the data with such a high quality that one could draw the same conclusions from the anonymized data as from the traditional pseudonymized individual-level research data. In addition, Findata – Sosiaali- ja terveysalan tietolupaviranomainen | Social and Health Data Permit Authority gave the consent to export the anonymous data from their secure IT environment to Bayer’s secure environment in Germany! #dataanonymization #ehds #clinicaltrials #externalcontrolarms #realworlddata
"Bayer decided to tackle the problem of lengthy and costly #clinicaltrials. In #Finland, they found a unique setting for their #FutureClinicalTrials project, with the right legislation, ecosystem, and mindset. The project has brought new solutions and made it possible to run clinical trials more efficiently, working with real-world data and advanced algorithms to optimize them. Thanks to the project, Bayer believes it is at the forefront of developing drugs in a more data-driven fashion." It has been an honor to drive this important 4-year project and to be a catalyst in building the #ecosystem. Kudos to #teambayer: Bernd Heinrich, Tea Vedenkannas, Natalia Lindholm, Luiz Giorgiani, Arto Pakkalin, Samu Kurki, Juho Immonen, Pekka Tiikkainen, Tarja Jalava and many others who have contributed and even bigger kudos to our partners and collaborators: Finnish Center for Artificial Intelligence, HUS Helsingin yliopistollinen sairaala, MedEngine, VEIL.AI, Taiste, DAIN Studios, Droice Labs, Business Finland, Fingenious®, Findata – Sosiaali- ja terveysalan tietolupaviranomainen | Social and Health Data Permit Authority
